PharmaCielo Ltd.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
11.3M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
TSXV
Key Financial Metrics
3.5M
Revenue
-9.1M
Net Income
-
EPS (Diluted)
-2.0M
Free Cash Flow
Profitability
Gross Margin
21.0%
Operating Margin
-140.9%
Net Profit Margin
-262.7%
EBITDA
-4.6M
Returns & Efficiency
Return on Assets (ROA)
-49.7%
Return on Equity (ROE)
-
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
18.4M
Total Debt
20.5M
Debt to Equity
-
Current Ratio
0.11
Company Info
| Industry | Drug Manufacturers - Specialty & Generic |
| HQ | Toronto, Canada |
| Fiscal Year End | 1743379200 |
| Currency | CAD |
| Website | www.pharmacielo.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
550,000
Shares Sold
0
Total Transactions
4
Interactive Charts
Company Profile
General Information
| Company Name | PharmaCielo Ltd. |
| Ticker | PCLO.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Headquarters | Toronto, Canada |
| Fiscal Year End | 1743379200 |
| Currency | CAD |
| Website | www.pharmacielo.com |
Financial Summary
| Market Cap | 11.3M |
| Revenue | 3.5M |
| Net Income | -9.1M |
| P/E Ratio | N/A |
| EPS (Diluted) | N/A |
| Net Margin | -262.7% |
| ROE | N/A |
| Dividend Yield | N/A |
Business Description
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.